Real-world treatment in patients with HER2+ metastatic breast cancer : Treatment decisions in HER2+ mBC
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1573-7217
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Real-world treatment in patients with HER2+ metastatic breast cancer ; day:23 ; month:11 ; year:2017 ; pages:1-9
Breast cancer research and treatment ; (23.11.2017), 1-9
- Classification
-
Medizin, Gesundheit
- Creator
-
Colomer, R.
- Contributor
-
Hall, P.
Szkultecka-Debek, M.
Bondi, R. C.
Flinois, A.
Auziere, S.
Cléac’h, J. Y. Le
SpringerLink (Online service)
- DOI
-
10.1007/s10549-017-4567-z
- URN
-
urn:nbn:de:1111-201801257420
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:57 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Colomer, R.
- Hall, P.
- Szkultecka-Debek, M.
- Bondi, R. C.
- Flinois, A.
- Auziere, S.
- Cléac’h, J. Y. Le
- SpringerLink (Online service)
Other Objects (12)
Updated Austrian treatment algorithm in HER2+ metastatic breast cancer
Clinicopathological features of HER2 positive metastatic colorectal cancer and survival analysis of anti-HER2 treatment
Real-world treatment patterns and outcomes of abemaciclib for the treatment of HR + , HER2- metastatic breast cancer patients in Japan
Real-world Outcomes of Dual HER2 Blockade Therapy in Metastatic HER2-Positive Breast Cancer: from Induction to Maintenance
Anti-HER2 Drugs for the Treatment of Advanced HER2 Positive Breast Cancer
Austrian treatment algorithms in HER2-positive metastatic breast cancer: a 2022 update
RC48-ADC treatment for patients with HER2-expressing locally advanced or metastatic solid tumors: a real-world study
Real-World Treatment Patterns and Outcomes Following First-Line Pertuzumab and Trastuzumab Among Patients with HER2+ Metastatic Breast Cancer
Treatment Options for Patients with Brain Metastatic Disease in HER2-Positive Breast Cancer
New treatment options for metastatic HER2-low breast cancer : Consequences for histopathological diagnosis
HER2-targeted advanced metastatic gastric/gastroesophageal junction adenocarcinoma: treatment landscape and future perspectives
Impact of low HER2 expression on response to CDK4/6 inhibitor treatment in advanced HR + /HER2- breast cancer: a multicenter real-world data analysis
Updated Austrian treatment algorithm in HER2+ metastatic breast cancer
Clinicopathological features of HER2 positive metastatic colorectal cancer and survival analysis of anti-HER2 treatment
Real-world treatment patterns and outcomes of abemaciclib for the treatment of HR + , HER2- metastatic breast cancer patients in Japan
Real-world Outcomes of Dual HER2 Blockade Therapy in Metastatic HER2-Positive Breast Cancer: from Induction to Maintenance
Anti-HER2 Drugs for the Treatment of Advanced HER2 Positive Breast Cancer
Austrian treatment algorithms in HER2-positive metastatic breast cancer: a 2022 update
RC48-ADC treatment for patients with HER2-expressing locally advanced or metastatic solid tumors: a real-world study
Real-World Treatment Patterns and Outcomes Following First-Line Pertuzumab and Trastuzumab Among Patients with HER2+ Metastatic Breast Cancer
Treatment Options for Patients with Brain Metastatic Disease in HER2-Positive Breast Cancer
New treatment options for metastatic HER2-low breast cancer : Consequences for histopathological diagnosis
HER2-targeted advanced metastatic gastric/gastroesophageal junction adenocarcinoma: treatment landscape and future perspectives
Impact of low HER2 expression on response to CDK4/6 inhibitor treatment in advanced HR + /HER2- breast cancer: a multicenter real-world data analysis
Updated Austrian treatment algorithm in HER2+ metastatic breast cancer
Clinicopathological features of HER2 positive metastatic colorectal cancer and survival analysis of anti-HER2 treatment
Real-world treatment patterns and outcomes of abemaciclib for the treatment of HR + , HER2- metastatic breast cancer patients in Japan
Real-world Outcomes of Dual HER2 Blockade Therapy in Metastatic HER2-Positive Breast Cancer: from Induction to Maintenance
Anti-HER2 Drugs for the Treatment of Advanced HER2 Positive Breast Cancer
Austrian treatment algorithms in HER2-positive metastatic breast cancer: a 2022 update
RC48-ADC treatment for patients with HER2-expressing locally advanced or metastatic solid tumors: a real-world study
Real-World Treatment Patterns and Outcomes Following First-Line Pertuzumab and Trastuzumab Among Patients with HER2+ Metastatic Breast Cancer
Treatment Options for Patients with Brain Metastatic Disease in HER2-Positive Breast Cancer
New treatment options for metastatic HER2-low breast cancer : Consequences for histopathological diagnosis
HER2-targeted advanced metastatic gastric/gastroesophageal junction adenocarcinoma: treatment landscape and future perspectives